학술논문
Correction to: Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase III Studies (SIGN Trials).
Document Type
Correction Notice
Author
Source
Subject
*ORAL drug administration
*BUMETANIDE
*AUTISM
*
*
Language
ISSN
0162-3257
Abstract
The author of the article would like to add a video abstract as a supplementary material for a published article. The supplementary file is published with this correction. The original article has been corrected. [ABSTRACT FROM AUTHOR]